Segment Information (Tables)

3 Months Ended

Dec. 31, 2012

Financial Information for Business Segments

Financial information for the Company’s business segments is as follows (in thousands):

	Brooks Product Solutions			Brooks Global Services		Brooks Life Science Systems			Total
Three months ended December 31, 2012
Revenues
Product	$	62,722		$	3,505	$	11,096		$	77,323
Services		—			17,660		3,042			20,702
	$	62,722		$	21,165	$	14,138		$	98,025
Gross profit	$	17,754		$	5,110	$	6,294		$	29,158
Segment operating income (loss)	$	(6,434	)	$	591	$	(22	)	$	(5,865	)
Three months ended December 31, 2011
Revenues
Product	$	85,294		$	2,377	$	9,427		$	97,098
Services		—			19,717		3,413			23,130
	$	85,294		$	22,094	$	12,840		$	120,228
Gross profit	$	28,401		$	7,136	$	4,820		$	40,357
Segment operating income (loss)	$	1,085		$	2,949	$	(633	)	$	3,401
Assets
December 31, 2012	$	249,849		$	68,323	$	103,182		$	421,354
September 30, 2012	$	218,799		$	56,120	$	107,530		$	382,449

Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment operating income (loss) to the corresponding consolidated amounts for the three month periods ended December 31, 2012 and 2011 is as follows (in thousands):

	Three months ended December 31,
	2012			2011
Segment operating income (loss)	$	(5,865	)	$	3,401
Other unallocated corporate expenses		890			518
Amortization of acquired intangible assets		1,552			1,217
Restructuring and other charges		4,757			203
Total operating income (loss)	$	(13,064	)	$	1,463

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of December 31, 2012 and September 30, 2012 is as follows (in thousands):

	December 31, 2012		September 30, 2012
Segment assets	$	421,354	$	382,449
Investments in cash, cash equivalents, restricted cash and marketable securities		142,757		200,994
Long-term deferred tax assets		101,135		104,626
Investments in joint ventures		30,437		31,428
Other unallocated corporate net assets		29,146		22,463
Total assets	$	724,829	$	741,960